IP Library Granted Patent US 7,659,092
Granted Patent B2
US 7,659,092 · App. 11/834,311 · Granted Feb 9, 2010

Fusion proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,659,092
App. No.
11/834,311
Granted
Feb 9, 2010
Kind
B2
Abstract

A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a Targeting Moiety that is capable of binding to a Binding Site on the nociceptive sensory afferent, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent. Nucleic acid sequences encoding the polypeptide fusion proteins, methods of preparing same and uses thereof are also described.

Claims (5)

1. A polypeptide comprising the amino acid sequence of SEQ ID NO. 64.

2. A nucleic acid encoding a polypeptide according to claim 1 .

3. A nucleic acid according to claim 2 comprising the nucleic acid sequence of SEQ ID NO. 63.

4. A nucleic acid vector comprising a nucleic acid according to claim 2 .

5. A method of making a polypeptide comprising the amino acid sequence of SEQ ID NO. 64, the method comprising expressing a nucleic acid vector according to claim 4 .

Assignments (1)
CHANGE OF NAME AND ADDRESS Recorded May 15, 2017
From: SYNTAXIN LIMITED
To: IPSEN BIOINNOVATION LIMITED
Reel/Frame 042458/0982 →